"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

PHASE3CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

JZP-110

Trial Locations (30)

15213

UPMC Sleep Medicine Center, Pittsburgh

19055

Klinische Forschung Schwerin GmbH, Schwerin

19104

Center for Sleep & Circadian Neurobiology, Philadelphia

20520

Turku University Hospital, Sleep Clinic, Turku

21224

Johns Hopkins Hospital, Baltimore

22182

American Sleep Medicine, Vienna

23510

EVMS Sleep Medicine, Norfolk

27710

Duke University Medical Center, Durham

28401

PMG Research of Wilmington, Wilmington

29406

Lowcountry Lung Critical Care, Charleston

29425

Medical University of South Carolina, Charleston

30329

Emory Sleep Center, Atlanta

32765

Oviedo Medical Research, LLC, Oviedo

33024

Broward Research Group, Inc., Hollywood

33200

Tampere University Hospital, Tampere

33511

PAB Clinical Research, Brandon

35213

Sleep Disorder Center of Alabama, Birmingham

38700

Grenoble University Hospital, La Tronche

44263

Somnolab Dortmund, Dortmund

66214

Rowe Neurology Institute RNI - Lenexa, Lenexa

66606

Veritas Clinical Specialities LTD, Topeka

70006

Advanced Neurodiagnostic Ceneter, Metairie

80228

Critical Care Pulmonary & Sleep Associates, LLC, Lakewood

86000

CHU de Poitiers, Poitiers

90404

Santa Monica Clinical Trials, Santa Monica

92056

The Research Center of Southern California, Oceanside

92868

SDS Clinical Trials, INC, Orange

02115

Brigham & Womens Hospital, Boston

00420

Helsinki Sleep Center, Helsinki

SE 413 45

Department of Sleep Medicine, Gӧteborg

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY